Home Compare EW vs JNJ
Stock Comparison · Structural lead, mixed market

Edwards Lifesciences vs Johnson & Johnson: Which Stock Looks Stronger in 2026?

Johnson & Johnson holds the cleaner structural position, with the lead spread across stability and valuation. Edwards Lifesciences does not offset that deficit through any equally strong structural edge elsewhere. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in stability, but valuation adds another real layer to the result. Johnson & Johnson leads by 19 points on the overall comparison score.

Trajectory Similarity
0.69
Moderately similar
Peer-set rank: #5
within Edwards Lifesciences Corporation's functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The match is driven mainly by operating margin level and revenue stability.

Similarity drivers
operating margin levelrevenue stability
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
EW
Edwards Lifesciences Corporation
54
Peer-Score
Signal qualityHigh
vs
JNJ
Johnson & Johnson
73
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: EW vs JNJ Profitability 78 69 Stability 49 86 Valuation 41 69 Growth 44 69 EW JNJ
Gap Ranking
#1 Stability +37
#2 Valuation +28
#3 Growth +25
#4 Profitability +9
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EW and JNJ Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EWJNJ Relative valuation Structural strength

Johnson & Johnson looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Both rank well on stability, but Johnson & Johnson still holds a clear edge.
Valuation
On valuation, the edge is clear — both rank well, but Johnson & Johnson sits noticeably higher.
Stability — Dominant Gap
EW
49
JNJ
86
Gap+37in favour of JNJ

The clearest distance comes from a steadier profile over time.

What keeps the gap from being one-sided

Edwards Lifesciences Corporation still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is built on both stability and valuation, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the EW vs JNJ comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-and-valuation comparisons

Explore how EW and JNJ each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.